Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03368651
PHASE3

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Sponsor: Sun Yat-sen University

View on ClinicalTrials.gov

Summary

To compare the impact on survival of neo-adjuvant TAI for patients with HCC and PVTT who underwent hepatectomy.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

230

Start Date

2016-01-01

Completion Date

2028-12-31

Last Updated

2017-12-11

Healthy Volunteers

No

Interventions

PROCEDURE

TAI

transarterial chemoinfusion with mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)

Locations (1)

Cancer Center of Sun Yat-Sen University

Guangzhou, Guangdong, China